TRELEGY ELLIPTA Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for TRELEGY ELLIPTA with the United States Patent and Trademark Office. The USPTO has given the TRELEGY ELLIPTA trademark a serial number of 88196660. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, June 13, 2025. This trademark is owned by Glaxo Group Limited. The TRELEGY ELLIPTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention, treatment, and/or alleviation of respiratory diseases and disorders; Pharmaceutical substances for the prevention, treatment, and/or alleviation of respiratory diseases and disorders
trelegy ellipta

General Information

Serial Number88196660
Word MarkTRELEGY ELLIPTA
Filing DateFriday, November 16, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, June 13, 2025
Registration Number5979239
Registration DateTuesday, February 4, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention, treatment, and/or alleviation of respiratory diseases and disorders; Pharmaceutical substances for the prevention, treatment, and/or alleviation of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code005
First Use Anywhere DateWednesday, September 18, 2019
First Use In Commerce DateTuesday, October 1, 2019

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 20, 2018NEW APPLICATION ENTERED
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Thursday, February 21, 2019PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
Thursday, February 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 21, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, February 21, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 21, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 18, 2019ASSIGNED TO LIE
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2019SOU EXTENSION 1 FILED
Monday, December 9, 2019SOU EXTENSION 1 GRANTED
Thursday, December 12, 2019TEAS STATEMENT OF USE RECEIVED
Friday, December 20, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 2, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 12, 2019USE AMENDMENT FILED
Friday, December 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 3, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 21, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, June 13, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 13, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, June 13, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 4, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

ellipta trelegy respiratory diseases disorders pharmaceutical alleviation treatment prevention substances preparations